The Hindu·3 min read·medium
Dr. Reddy’s halts semaglutide supplies on quality concerns, shares plunge, Torrent recalls product
N
N. Ravi Kumar
✦AI Summary
Dr. Reddy’s Laboratories has halted commercial supplies of its generic semaglutide due to quality concerns regarding an active pharmaceutical ingredient. The announcement caused the company's shares to drop, and Torrent Pharmaceuticals has initiated a voluntary recall of affected batches.
Dr. Reddy’s Laboratories on Thursday said it has halted commercial supplies of its generic semaglutide after an issue associated with the active pharmaceutical ingredient (API) used in the drug and fresh despatches were likely to resume only towards late October or early November.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in